| Leah Kathryn Swenson, FNP | |
|
132 4th Ave Ne, Valley City, ND 58072-3056 | |
| (701) 845-8060 | |
| (701) 845-8067 |
| Full Name | Leah Kathryn Swenson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 16 Years |
| Location | 132 4th Ave Ne, Valley City, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891942405 | NPI | - | NPPES |
| 1458623 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | R23542 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Essentia Health | Fargo, ND | Hospital |
| Chi Mercy Health | Valley city, ND | Hospital |
| Jamestown Regional Medical Center | Jamestown, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Innovis Health Llc | 9931298155 | 473 |
News Archive
The University of Nottingham spin-out company, Oncimmune Ltd, has developed a ground breaking blood test which will aid the detection of cancer as much as five years earlier than current testing methods such as mammography and CT scans. Physicians will know the result of their patient's test within one week of sending in a blood sample to Oncimmune.
Group of researchers at Kaunas University of Technology, Lithuania are developing new generation sponge-like wound dressings with hyaluronic acid. Antimicrobial, antioxidant, anti-inflammatory wound dressings stimulate tissue regeneration and can be especially efficient in treating deep wounds that are difficult to heal.
Percutanous angioplasty involves insertion of a stent into a blocked or narrowed coronary artery that eases the blood flow and relieves the pain of severe angina or a heart attack. It is being routinely practiced worldwide. A new study called ORBITA, has revealed that not all patients who undergo this procedure benefit from it.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.
› Verified 4 days ago
| Entity Name | Innovis Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215125463 PECOS PAC ID: 9931298155 Enrollment ID: O20071211000158 |
News Archive
The University of Nottingham spin-out company, Oncimmune Ltd, has developed a ground breaking blood test which will aid the detection of cancer as much as five years earlier than current testing methods such as mammography and CT scans. Physicians will know the result of their patient's test within one week of sending in a blood sample to Oncimmune.
Group of researchers at Kaunas University of Technology, Lithuania are developing new generation sponge-like wound dressings with hyaluronic acid. Antimicrobial, antioxidant, anti-inflammatory wound dressings stimulate tissue regeneration and can be especially efficient in treating deep wounds that are difficult to heal.
Percutanous angioplasty involves insertion of a stent into a blocked or narrowed coronary artery that eases the blood flow and relieves the pain of severe angina or a heart attack. It is being routinely practiced worldwide. A new study called ORBITA, has revealed that not all patients who undergo this procedure benefit from it.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leah Kathryn Swenson, FNP Po Box 6001, Fargo, ND 58108-6001 Ph: (701) 845-8060 | Leah Kathryn Swenson, FNP 132 4th Ave Ne, Valley City, ND 58072-3056 Ph: (701) 845-8060 |
News Archive
The University of Nottingham spin-out company, Oncimmune Ltd, has developed a ground breaking blood test which will aid the detection of cancer as much as five years earlier than current testing methods such as mammography and CT scans. Physicians will know the result of their patient's test within one week of sending in a blood sample to Oncimmune.
Group of researchers at Kaunas University of Technology, Lithuania are developing new generation sponge-like wound dressings with hyaluronic acid. Antimicrobial, antioxidant, anti-inflammatory wound dressings stimulate tissue regeneration and can be especially efficient in treating deep wounds that are difficult to heal.
Percutanous angioplasty involves insertion of a stent into a blocked or narrowed coronary artery that eases the blood flow and relieves the pain of severe angina or a heart attack. It is being routinely practiced worldwide. A new study called ORBITA, has revealed that not all patients who undergo this procedure benefit from it.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.
› Verified 4 days ago
Kari Marie Kietzman, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 520 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6000 Fax: 701-845-6150 | |
Sarah Ellen Hansen, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 132 4th Ave Ne, Valley City, ND 58072 Phone: 701-845-8060 | |
Stacie Cleveland, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 367 2nd St Nw, Valley City, ND 58072 Phone: 701-845-6550 | |
Trent William Bitz, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 132 4th Ave Ne, Valley City, ND 58072 Phone: 701-845-8060 | |
Dr. Joann Delane Trader, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 520 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6000 | |
Gregory D Pfennig, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 520 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6000 Fax: 701-845-6150 |